COVAX, a global initiative to ensure rapid and equitable access to Covid-19 vaccines for all countries, regardless of income level, has announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine, which has already received WHO emergency use listing.